Edgewise Therapeutics, Inc. (EWTX)

NASDAQ: EWTX · Real-Time Price · USD

29.94

-1.05 (-3.39%)

At close: Mar 12, 2026, 4:00 PM EDT

30.12

+0.18 (0.60%)

After-hours: Mar 12, 2026, 4:23 PM EDT

Edgewise Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	40.02	31.87	23.45	17.63	11.03
Research & Development	151.39	126.97	90.91	54.03	32.19
Total Operating Expenses	191.41	158.83	114.36	71.66	43.22
Operating Income	-191.41	-158.83	-114.36	-71.66	-43.22
Interest Income	23.61	25.02	14.19	4.02	0.4
Total Non-Operating Income (Expense)	23.61	25.02	14.19	4.02	0.4
Pretax Income	-167.8	-133.81	-100.16	-67.64	-42.81
Net Income	-167.8	-133.81	-100.16	-67.64	-42.81
Net Income to Common	-167.8	-133.81	-100.16	-67.64	-42.81
Shares Outstanding (Basic)	103	92	64	54	38
Shares Outstanding (Diluted)	103	92	64	54	38
Shares Change (YoY)	11.38%	45.02%	18.90%	42.82%	4977.96%
EPS (Basic)	-1.63	-1.45	-1.57	-1.26	-1.14
EPS (Diluted)	-1.63	-1.45	-1.57	-1.26	-1.14
Free Cash Flow	-144.07	-110.34	-97.69	-58.18	-34.18
Free Cash Flow Per Share	-1.40	-1.19	-1.53	-1.09	-0.91
EBITDA	-189.14	-156.54	-112.63	-71.12	-42.94
EBIT	-191.41	-158.83	-114.36	-71.66	-43.22

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q